Pharmacy experts with the analytics and insights to bring objective truth, knowledge, and understanding to pharmacy.
If you manage pharmacy benefits for your organization, we have the expertise and technology to access the best plan options most affordably.
On May 17, 2022, the U.S. District Court for DC ruled against the “accumulator adjustment rule.” What impact will this have on pharma?
340B is increasingly a part of the pharmacy conversation. How should stakeholders react to the program?
Several states have passed legislation that prohibits the use of copay accumulator adjustment programs. How does this affect your organization?